| | | | | |
PRQR ProQR Therapeutics N.V. Ordinary Shares | €1,2706 | +0,34% | €141,58M | €560,32K | |
NAZ Nuveen Arizona Quality Municipal Income Fund | €11,3188 | +1,55% | €141,56M | €28,61K | |
| €2,0932 | -2,80% | €141,50M | €295,23K | |
AMWL American Well Corporation | €7,2874 | -0,47% | €141,48M | €133,09K | |
| €45,2752 | -1,59% | €141,42M | €7,76K | |
SPRO Spero Therapeutics, Inc. Common Stock | €2,4119 | -1,06% | €141,15M | €648,90K | |
| €1,4644 | -3,95% | €140,95M | €694,98K | |
NMP NMP Acquisition Corp. Class A Ordinary Shares | €8,8164 | -0,05% | €140,59M | €1,27K | |
GLQ Clough Global Equity Fund | €7,4425 | -0,35% | €140,58M | €54,79K | |
MNSB MainStreet Bancshares, Inc. Common Stock | €19,5796 | -2,15% | €140,33M | €31,41K | |
ORMP Oramed Pharmaceuticals Inc. | €3,1441 | +1,39% | €139,95M | €310,02K | |
CPSH CPS Technologies Corp. Common Stock | €6,7792 | -14,80% | €139,91M | €2,21M | |
NNY Nuveen New York Municipal Value Fund | €7,4080 | -0,23% | €139,74M | €17,67K | |
VTN Invesco Trust for Investment Grade New York Municipals | €9,5012 | +0,36% | €139,63M | €8,39K | |
KORE KORE Group Holdings, Inc. | €7,9163 | +0,00% | €139,07M | €20,57K | |
